Product
[212Pb]VMT01
Name
[212Pb]VMT01
1 clinical trial
6 indications
Indication
MelanomaIndication
Metastatic MelanomaIndication
melanomaIndication
UvealIndication
Mucosal melanomaIndication
Melanoma stage IIIClinical trial
A Phase I/IIa, First-In-Human, Multi-Center Dose Escalation and Dose Expansion Study of [203/212Pb]VMT01 Receptor-Targeted, Image-Guided Alpha-Particle Therapy in Patients With Previously Treated Unresectable or Metastatic MelanomaStatus: Recruiting, Estimated PCD: 2025-06-30